8,440 Shares in iShares Biotechnology ETF $IBB Purchased by WorthPointe LLC

WorthPointe LLC bought a new stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 8,440 shares of the financial services provider’s stock, valued at approximately $1,424,000.

Other hedge funds have also made changes to their positions in the company. Allspring Global Investments Holdings LLC raised its holdings in shares of iShares Biotechnology ETF by 46,806.0% during the fourth quarter. Allspring Global Investments Holdings LLC now owns 46,906 shares of the financial services provider’s stock valued at $7,927,000 after acquiring an additional 46,806 shares during the last quarter. Aster Capital Management DIFC Ltd acquired a new position in shares of iShares Biotechnology ETF during the third quarter valued at approximately $1,907,000. Central Pacific Bank Trust Division raised its holdings in shares of iShares Biotechnology ETF by 296,500.0% during the fourth quarter. Central Pacific Bank Trust Division now owns 14,830 shares of the financial services provider’s stock valued at $2,503,000 after acquiring an additional 14,825 shares during the last quarter. Florin Court Capital LLP acquired a new position in shares of iShares Biotechnology ETF during the third quarter valued at approximately $11,116,000. Finally, SG Americas Securities LLC raised its holdings in shares of iShares Biotechnology ETF by 96.3% during the third quarter. SG Americas Securities LLC now owns 28,569 shares of the financial services provider’s stock valued at $4,125,000 after acquiring an additional 14,016 shares during the last quarter. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

Shares of iShares Biotechnology ETF stock opened at $175.99 on Thursday. The business has a 50 day simple moving average of $170.17 and a two-hundred day simple moving average of $166.81. iShares Biotechnology ETF has a 12 month low of $116.25 and a 12 month high of $179.64.

iShares Biotechnology ETF Cuts Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, March 20th. Shareholders of record on Tuesday, March 17th were issued a dividend of $0.1218 per share. The ex-dividend date of this dividend was Tuesday, March 17th. This represents a $0.49 dividend on an annualized basis and a dividend yield of 0.3%.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.